Synergies: Revenue vs Cost
The extra value two companies can create together that they could not apart - split into harder-to-capture revenue gains and more reliable cost savings.
What it is
Synergies are the value a combined company can create that the two firms could not create separately - the whole being worth more than the sum of its parts. They come in two flavours with very different reliability. Cost synergies are savings from removing duplication: one headquarters instead of two, combined purchasing power, shared systems. Revenue synergies are new sales the combination unlocks: cross-selling one firm's products to the other's customers, entering a market faster together. The key insight for any deal is that cost synergies are generally more concrete and more capturable, while revenue synergies are more speculative, slower, and easier to overpromise - so they deserve far more scepticism.
When to use it
Use it in any merger, acquisition, or partnership case where the question is whether the deal creates value and how much to pay. Synergies are usually the justification for paying a premium over standalone value, so evaluating them honestly is central. It is also the lens for post-merger integration priorities. It is less relevant for pure market-entry or operational questions with no combination involved. Do not accept a synergy figure at face value - the discipline is to separate the reliable savings from the hopeful growth and to weigh the cost of capturing each.
How to apply it
Split the claimed synergies cleanly into cost and revenue, and treat them differently. For cost synergies, identify the specific duplication being removed and ask whether it is truly redundant and how long it takes to realize (severance, system migration, and contract lock-ins delay savings). For revenue synergies, be much harder: name the exact mechanism (which product, to whose customers, at what attach rate), and discount heavily because customers do not automatically buy more just because two firms merged. Net out the one-time cost to achieve the synergies and the risk of dis-synergies (customer or talent loss, culture clash). Then compare the risk-adjusted synergy value to the premium being paid - synergies only justify a deal if they exceed what you overpay to get them.
Common mistakes
The signature error is crediting revenue synergies at full value and on an optimistic timeline; they are the most overpromised and least delivered part of most deals. Another is ignoring the cost to achieve synergies - integration, severance, and system work can consume much of the savings for years. People also forget dis-synergies: mergers can lose customers who dislike consolidation and talent who leave, which offsets the gains. And they justify a premium by pointing at gross synergies without checking whether the risk-adjusted, net-of-cost figure actually clears the price paid.
Example
A national pharmacy chain proposes acquiring a regional rival, justifying the price with 200 million of annual synergies. Splitting them: about 140 million is cost - closing overlapping distribution centers and combining purchasing - which is concrete, though it needs two years and 90 million of one-time integration spend to unlock. The other 60 million is revenue synergy from 'cross-selling health services', which rests on assumptions about attach rates that have no track record. Weighing the two differently, the defensible synergy value is closer to the cost bucket, net of the cost to achieve it, and the fragile revenue piece should not be funding the acquisition premium. That reframing changes both whether to do the deal and how much to pay.
Practice it
Practice on M&A cases by always separating cost from revenue synergies, discounting the revenue side hard, netting out the cost and time to capture, and testing whether the risk-adjusted figure justifies the premium. The skill to build is scepticism about synergy claims - grounding each in a specific mechanism rather than accepting a headline number.